Importantly, Liu et al. showed that the decrease in the levels of phosphorylated and total p85α was more prominent in the brain of these comorbid patients as compared to AD patients without T2D, and that the alterations in p85α coincided with altered phosphorylation of the downstream targets AKT and GSK3β [97]. Here, GSK3B is linked to Alzheimer disease.